Write a reviewFor vendors
♡
Home / Investors / Amel Tounsi

Amel Tounsi

Venture Fund · Belgium

About Amel Tounsi

Venture capital investor (Chief Executive Officer) based in Belgium. Focus areas include Patient Care, Health Care, Research and Development. Invests at seed stage. Past investments include Amyl Therapeutics.

Investment focus

Stages
Seed
Sectors
Patient CareHealth CareResearch and DevelopmentHospitalsWellnessInfrastructureHealthcare InnovationLife ScienceEngineeringEducationBusiness DevelopmentBiotechnologyMedical DevicesInnovationNeuroscienceResearchTechnology TransferProfessional NetworkingMedicalB2B

Portfolio

No portfolio companies recorded yet; Amel Tounsi reports 1 investments overall.

Similar investors

Aaref Hilaly

Angel Investor · San Francisco
SeedSeries BEarly Stage VentureSeries AHealth CareData IntegrationTalent ManagementE-commerce+16
60Investments
—Exits

Aaron Bast

Venture Fund · Kitchener
SeedEarly Stage VentureAdvertisingHealth CareAccountingPayments+16
60Investments
—Exits

Abbie Celniker

Venture Fund · Newton
SeedHealth CareDrug DiscoveryAutoimmune DiseasesWellness+16
60Investments
—Exits

Abhinaya Konduru

Venture Fund · Chicago
SeedPre-SeedEarly Stage VentureHealth CareE-commercePaymentsCybersecurity+16
60Investments
—Exits

Adam Cragg

Angel Investor · Calgary
SeedPre-SeedEarly Stage VentureSeries AAdvertisingHealth CareCybersecurityEnterprise Software+16
60Investments
—Exits

Adam Rothenberg

Angel Investor · New York City
SeedPre-SeedEarly Stage VentureSeries AHealth CareE-commerceMessagingDisruptive Innovation+16
60Investments
—Exits